Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-pacific region

Hypertension

Volumn 59, Issue 6, 2012, Pages 1118-1123

  Arima, Hisatomi ^a   Murakami, Yoshitaka ^a   Lam, Tai Hing ^b   Kim, Hyeon Chang ^c,d   Ueshima, Hirotsugu ^e   Woo, Jean ^f   Suh, Il ^c   Fang, Xianghua ^g   Woodward, Mark ^a,h  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Yonsei University College of Medicine   (South Korea)

^d NORTHWESTERN UNIVERSITY   (United States)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Coronary heart disease; Hypertension; Hypertension subtype; Isolated diastolic hypertension; Prehypertension; Stroke

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; ISOLATED SYSTOLIC HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREHYPERTENSION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SMOKING; SYSTOLIC DIASTOLIC HYPERTENSION;

ADULT; AGED; AGED, 80 AND OVER; ASIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIASTOLE; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OCEANIA; PREHYPERTENSION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SYSTOLE;

EID: 84861529123     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.187252     Document Type: Article

References (41)

1. World Health Organization. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2004.
2. World Health Organization. Preventing Chronic Disease: A Vital Investment. Geneva, Switzerland: World Health Organization; 2005.
3. Lawes CM, Vander Hoorn S, Rodgers A, for the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518.
4. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
5. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular diseases in the Asia-Pacific region. J Hypertens. 2003;21: 707-716.
6. Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension. 2003;42:69-75.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, and the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
8. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
9. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clement D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-2158.
10. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2011 update-a report from the American Heart Association. Circulation. 2011;123:e18-e209.
11. Agyemang C, van Valkengoed I, van den Born BJ, Stronks K. Prevalence and determinants of prehypertension among African Surinamese, Hindustani Surinamese, and White Dutch in Amsterdam, the Netherlands: the SUNSET Study. Eur J Cardiovasc Prev Rehabil. 2007;14:775-781.
12. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. Distribution of major health risks: findings from the Global Burden of Disease Study. PLoS Med. 2004;1:e27.
13. He J, Gu D, Chen J, Wu X, Kelly TN, Huang JF, Chen JC, Chen CS, Bazzano LA, Reynolds K, Whelton PK, Klag MJ. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet. 2009;374:1765-1772.
14. Gu D, Chen J, Wu X, Duan X, Jones DW, Huang JF, Chen CS, Chen JC, Kelly TN, Whelton PK, He J. Prehypertension and risk of cardiovascular disease in Chinese adults. J Hypertens. 2009;27:721-729.
15. Kaplan NM, Victor RG., Kaplan's Clinical Hypertension. Philadelphia, PA: Lippincott Williams and Wilkins; 2010.
16. Petrovitch H, Curb JD, Bloom-Marcus E. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke. 1995;26:25-29.
17. Nielsen WB, Lindenstrom E, Vestbo J, Jensen GB. Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens. 1997;10:634-639.
18. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama Study. Arch Intern Med. 2000;160:3301-3306.
19. Strandberg TE, Salomaa VV, Vanhanen HT, Pitkala K, Miettinen TA. Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. J Hypertens. 2002;20:399-404.
20. Fang XH, Zhang XH, Yang QD, Dai XY, Su FZ, Rao ML, Wu SP, Du XL, Wang WZ, Li SC. Subtype hypertension and risk of stroke in middle-aged and older Chinese: a 10-year follow-up study. Stroke. 2006; 37:38-43.
21. Kelly TN, Gu D, Chen J, Huang JF, Chen JC, Duan X, Wu X, Yau CL, Whelton PK, He J. Hypertens subtype and risk of cardiovascular disease in Chinese adults. Circulation. 2008;118:1558-1566.
22. Fang J, Madhavan S, Cohen H, Alderman MH. Isolated diastolic hypertension: a favorable finding among young and middle-aged hypertensive subjects. Hypertension. 1995;26:377-382.
23. Franklin SS, Wilkinson IB, McEniery CM. Unusual hypertensive phenotypes: what is their significance? Hypertension. 2012;59:173-178.
24. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37:869-874.
25. Asia Pacific Cohort Studies Collaboration. Determinants of cardiovascular disease in the Asia Pacific region: protocol for a collaborative overview of cohort studies. Cardiovasc Dis Prev. 1999;2:281-289.
26. Woodward M, Barzi F, Martiniuk A, Fang X, Gu DF, Imai Y, Lam TH, Pan WH, Rodgers A, Suh I, Jee SH, Ueshima H, Huxley R. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol. 2006;35:1412-1416.
27. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
28. Liszka HA, Mainous AG III, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005;3:294-299.
29. Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR, for the Women's Health Initiative Investigators. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation. 2007;115:855-860.
30. Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007;335:432.
31. Murakami Y, Hozawa A, Okamura T, Ueshima H, and the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan Research Group (EPOCH-JAPAN). Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension. 2008;51:1483-1491.
32. Asayama K, Ohkubo T, Yoshida S, Suzuki K, Metoki H, Harada A, Murakami Y, Ohashi Y, Ueshima H, Imai Y, the Japan Arteriosclerosis Longitudinal Study (JALS) group. Stroke risk and antihypertensive drug treatment in the general population: the Japan Arteriosclerosis Longitudinal Study. J Hypertens. 2009;27:357-364.
33. Ishikawa Y, Ishikawa J, Ishikawa S, Kajii E, Schwartz JE, Pickering TG, Kario K, and the Jichi Medical School Cohort Investigators Group. Prehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study. J Hypertens. 2010;28:1630-1637.
34. Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, MacMahon S, Neal B, for the PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS Trial. J Hypertens. 2006;24:1201-1208.
35. Perry HM Jr, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL, for the Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000; 284:465-471.
36. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
37. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527-1535.
38. Rodgers A, Chapman N, Woodward M, Liu L-S, Colman S, Lee A, Chalmers J, MacMahon S, on behalf of the PROGRESS Collaborative Group. Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. J Hypertens. 2004;22:653-659.
39. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121-1123.
40. Arima H, Anderson C, Omae T, Liu L, Tzourio C, Woodward M, MacMahon S, Neal B, Rodgers A, Chalmers J, for the PROGRESS Collaborative Group. Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS Trial. J Hypertens. 2010;28:395-400.
41. Arima H, Anderson C, Omae T, Woodward M, Hata J, Murakami Y, Macmahon S, Neal B, Chalmers J, for the PROGRESS Collaborative Group. Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial. Stroke. 2011;42:2339-2341.